Morgan Cantley, PharmD, BCOP
Advertisement
Articles by Morgan Cantley, PharmD, BCOP
Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan.
Advertisement
Latest Updated Articles
Trastuzumab and HER2-Targeted Therapy: Breaking Down the BasicsAugust 15th 2025
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
3
Pharmacist Outreach Doubles SGLT2 Inhibitor Uptake in CKD
4
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
5